These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1372856)

  • 1. Fosinopril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in essential hypertension.
    Murdoch D; McTavish D
    Drugs; 1992 Jan; 43(1):123-40. PubMed ID: 1372856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fosinopril: a reappraisal of its pharmacology and therapeutic efficacy in essential hypertension.
    Wagstaff AJ; Davis R; McTavish D
    Drugs; 1996 May; 51(5):777-91. PubMed ID: 8861547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjects.
    Duchin KL; Waclawski AP; Tu JI; Manning J; Frantz M; Willard DA
    J Clin Pharmacol; 1991 Jan; 31(1):58-64. PubMed ID: 1646240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fosinopril/hydrochlorothiazide: single dose and steady-state pharmacokinetics and pharmacodynamics.
    O'Grady P; Yee KF; Lins R; Mangold B
    Br J Clin Pharmacol; 1999 Sep; 48(3):375-81. PubMed ID: 10510149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive effect of fosinopril, a new angiotensin converting enzyme inhibitor: findings of the Fosinopril Study Group II.
    Pool JL
    Clin Ther; 1990; 12(6):520-33. PubMed ID: 2149674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fosinopril. Clinical pharmacokinetics and clinical potential.
    Shionoiri H; Naruse M; Minamisawa K; Ueda S; Himeno H; Hiroto S; Takasaki I
    Clin Pharmacokinet; 1997 Jun; 32(6):460-80. PubMed ID: 9195116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of fosinopril in patients with various degrees of renal function.
    Hui KK; Duchin KL; Kripalani KJ; Chan D; Kramer PK; Yanagawa N
    Clin Pharmacol Ther; 1991 Apr; 49(4):457-67. PubMed ID: 1826651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the steady-state pharmacokinetics of fosinopril, lisinopril and enalapril in patients with chronic renal insufficiency.
    Sica DA; Cutler RE; Parmer RJ; Ford NF
    Clin Pharmacokinet; 1991 May; 20(5):420-7. PubMed ID: 1652404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure lowering and renal hemodynamic effects of fosinopril in conscious animal models.
    DeForrest JM; Waldron TL; Harvey C; Scalese B; Mitch S; Powell JR; Petrillo W; Cushman DW
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):139-46. PubMed ID: 1696656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fosinopril and hydrochlorothiazide in patients with mild to moderate hypertension.
    Forslund T; Franzén P; Backman R
    J Intern Med; 1991 Dec; 230(6):511-7. PubMed ID: 1836220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment.
    Ford NF; Lasseter KC; Van Harken DR; Hammett JL; Raymond R; Manning J
    J Clin Pharmacol; 1995 Feb; 35(2):145-50. PubMed ID: 7751424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Once-daily fosinopril in the treatment of hypertension.
    Anderson RJ; Duchin KL; Gore RD; Herman TS; Michaels RS; Nichola PS; Nolen TM; Wolfson P; Wombolt DG; Zusman R
    Hypertension; 1991 May; 17(5):636-42. PubMed ID: 1827086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fosinopril. A review of its pharmacology and clinical efficacy in the management of heart failure.
    Davis R; Coukell A; McTavish D
    Drugs; 1997 Jul; 54(1):103-16. PubMed ID: 9211084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trandolapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in essential hypertension.
    Wiseman LR; McTavish D
    Drugs; 1994 Jul; 48(1):71-90. PubMed ID: 7525196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosinopril (Staril)--another ACE inhibitor.
    Drug Ther Bull; 1991 Jun; 29(12):48. PubMed ID: 1834450
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity].
    Rosolová H; Cech J; Sefrna F
    Vnitr Lek; 2001 Dec; 47(12):834-9. PubMed ID: 11826546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of senile hypertension: the Fosinopril in Old Patients Study (FOPS).
    Vetter W
    Am J Hypertens; 1997 Oct; 10(10 Pt 2):255S-261S. PubMed ID: 9366282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate and short-term cardiovascular effects of fosinopril, a new angiotensin-converting enzyme inhibitor, in patients with essential hypertension.
    Oren S; Messerli FH; Grossman E; Garavaglia GE; Frohlich ED
    J Am Coll Cardiol; 1991 Apr; 17(5):1183-7. PubMed ID: 1826120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fosinopril on cardiac function in patients with hypertension. Radionuclide assessment of left ventricular systolic and diastolic performance.
    Zusman RM; Christensen DM; Higgins J; Boucher CA
    Am J Hypertens; 1992 Apr; 5(4 Pt 1):219-23. PubMed ID: 1534664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients.
    Gehr TW; Sica DA; Grasela DM; Duchin KL
    Eur J Clin Pharmacol; 1993; 45(5):431-6. PubMed ID: 8112372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.